8-K: Waystar Reports 20% Revenue Growth in Second Quarter 2024, Despite Net Loss
Quarterly Report
Waystar Holding Corp. announced a 20% year-over-year revenue increase for the second quarter of 2024, alongside a net loss of $27.7 million, but with positive adjusted EBITDA.
Summary
- Waystar reported its financial results for the second quarter of 2024, showing a 20% increase in revenue compared to the same period last year, reaching $234.5 million.
- The company experienced a net loss of $27.7 million, which translates to a net loss margin of (11.8)%.
- However, Waystar achieved a non-GAAP net income of $5.0 million and an adjusted EBITDA of $93.9 million, with an adjusted EBITDA margin of 40%.
- The company's cash flow from operations was $15.5 million, and its unlevered free cash flow was $50.3 million.
- Waystar's key metrics include 1,117 clients contributing over $100,000 in LTM revenue, a 9% year-over-year increase, and a net revenue retention rate of 108%.
- For the full fiscal year 2024, Waystar expects total revenue to be between $902 million and $918 million, adjusted EBITDA between $360 million and $368 million, and non-GAAP net income between $36 million and $42 million.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to strong revenue growth and adjusted EBITDA, but tempered by the net loss. The company's future outlook is also positive, contributing to the overall sentiment.
Positives
- Waystar demonstrated strong revenue growth of 20% year-over-year in Q2 2024.
- The company achieved a solid adjusted EBITDA margin of 40%, indicating efficient operations.
- Waystar's net revenue retention rate of 108% suggests strong customer loyalty and expansion.
- The number of clients contributing over $100,000 in LTM revenue increased by 9% year-over-year, showing growth in key accounts.
- The company's unlevered free cash flow was a healthy $50.3 million.
- Waystar provided positive full-year 2024 guidance for revenue, adjusted EBITDA, and non-GAAP net income.
Negatives
- Waystar reported a net loss of $27.7 million for the second quarter of 2024.
- The company's net loss margin was (11.8)%, indicating that expenses are significantly outpacing revenue on a GAAP basis.
- The company has a significant amount of long term debt at $1,301,208 thousand.
Risks
- Waystar operates in a highly competitive industry, which could impact its ability to retain and attract clients.
- The company's success depends on its ability to execute its business strategies and integrate acquired businesses.
- Changes in the healthcare regulatory landscape could negatively affect Waystar's revenue.
- The company is exposed to risks related to data privacy, security breaches, and compliance with regulations.
- Waystar's financial performance is subject to macroeconomic conditions and interest rate fluctuations.
- The company's reliance on third-party vendors and providers poses a risk to its operations.
Future Outlook
Waystar expects total revenue between $902 million and $918 million, adjusted EBITDA between $360 million and $368 million, and non-GAAP net income between $36 million and $42 million for the full fiscal year 2024.
Management Comments
- Waystar delivered strong performance across all key metrics in Q2, said Matt Hawkins, Waystars CEO.
- We have solid momentum as clients utilize the cloud-based Waystar software platform, which we have purpose-built to drive client return on investment and a differentiated, modern user experience.
- There is meaningful opportunity ahead of us, as the demand for an innovative healthcare software payment platform has never been greater.
- Waystar is poised to continue to deliver an attractive combination of revenue growth at scale and compelling adjusted EBITDA margins.
Industry Context
Waystar's results reflect the ongoing demand for healthcare payment software solutions, as the industry continues to seek efficiency and cost reduction. The company's focus on cloud-based solutions and user experience aligns with current trends in the healthcare technology sector.
Comparison to Industry Standards
- Waystar's 20% revenue growth is strong compared to some established players in the healthcare technology space, such as Change Healthcare (now part of UnitedHealth Group), which has seen more modest growth rates in recent periods.
- The 40% adjusted EBITDA margin is competitive with other SaaS companies in the healthcare sector, such as Veeva Systems, which often reports high profitability margins.
- However, the net loss of $27.7 million highlights the challenges of achieving profitability while investing in growth, a common theme among rapidly expanding tech companies.
- The 108% net revenue retention rate is a positive indicator of customer satisfaction and is comparable to other successful SaaS businesses, such as Salesforce, which also focus on recurring revenue models.
Stakeholder Impact
- Shareholders may be encouraged by the revenue growth and adjusted EBITDA, but concerned about the net loss.
- Employees may be motivated by the company's growth and positive outlook.
- Customers should benefit from the company's continued investment in its platform.
- Suppliers and creditors may view the company's financial health as stable, but will monitor the net loss.
Next Steps
- Waystar will host a conference call to discuss the financial results on August 7, 2024.
- The company will continue to focus on growing its client base and expanding its platform capabilities.
- Waystar will monitor its financial performance against its full-year 2024 guidance.
Key Dates
| Date | Description |
|---|---|
| August 7, 2024 | Date of the earnings release and 8-K filing, also the date of the conference call to discuss the results. |
| June 30, 2024 | End of the fiscal quarter for which results are reported. |
Keywords
healthcare payment software, revenue growth, adjusted EBITDA, net loss, financial results, SaaS, net revenue retention, non-GAAP net income, financial guidance, Waystar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.